Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N C Saccoia

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Therapeutic Drug Monitoring|July 1, 1991
Improved high-performance liquid chromatography assay for atenolol in plasma and urine using fluorescence detectionR G Morris, N C Saccoia, B C Sallustio, et al.
Palliative Medicine|October 1, 1996
Dextromoramide pharmacokinetics following sublingual administrationT E Jones, R G Morris, N C Saccoia, et al.
Therapeutic Drug Monitoring|December 1, 1996
Enzyme-multiplied immunoassay (EMIT 2000) digoxin assay compared with fluorescence polarization immunoassay and amerlex 125I-radioimmunoassay at two Australian centersN C Saccoia, L P Hackett, R G Morris, et al.
Therapeutic Drug Monitoring|April 1, 1997
Reducing the cost of cyclosporin assays: modification of the EMIT 2000 methodB C Sallustio, R G Morris, N C Saccoia, et al.
Therapeutic Drug Monitoring|June 1, 1992
Specific enzyme-multiplied immunoassay and fluorescence polarization immunoassay for cyclosporin compared with Cyclotrac [125I]radioimmunoassayR G Morris, N C Saccoia, R G Ryall, et al.
Therapeutic Drug Monitoring|October 1, 1993
Experiences with the enzyme-multiplied immunoassay cyclosporine specific assay in a therapeutic drug monitoring laboratoryR G Morris, N C Saccoia, B C Sallustio, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Interference from digoxin-like immunoreactive substance(s) in commercial digoxin kit assay methodsR G Morris, D B Frewin, N C Saccoia, et al.
Therapeutic Drug Monitoring|January 1, 1989
Alteration in doxorubicin and doxorubicinol plasma concentrations with repeated courses to patientsR G Morris, P A Reece, B M Dale, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Therapeutic Drug Monitoring|July 1, 1991
Improved high-performance liquid chromatography assay for atenolol in plasma and urine using fluorescence detectionR G Morris, N C Saccoia, B C Sallustio, et al.
Palliative Medicine|October 1, 1996
Dextromoramide pharmacokinetics following sublingual administrationT E Jones, R G Morris, N C Saccoia, et al.
Therapeutic Drug Monitoring|December 1, 1996
Enzyme-multiplied immunoassay (EMIT 2000) digoxin assay compared with fluorescence polarization immunoassay and amerlex 125I-radioimmunoassay at two Australian centersN C Saccoia, L P Hackett, R G Morris, et al.
Therapeutic Drug Monitoring|April 1, 1997
Reducing the cost of cyclosporin assays: modification of the EMIT 2000 methodB C Sallustio, R G Morris, N C Saccoia, et al.
Therapeutic Drug Monitoring|June 1, 1992
Specific enzyme-multiplied immunoassay and fluorescence polarization immunoassay for cyclosporin compared with Cyclotrac [125I]radioimmunoassayR G Morris, N C Saccoia, R G Ryall, et al.
Therapeutic Drug Monitoring|October 1, 1993
Experiences with the enzyme-multiplied immunoassay cyclosporine specific assay in a therapeutic drug monitoring laboratoryR G Morris, N C Saccoia, B C Sallustio, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Interference from digoxin-like immunoreactive substance(s) in commercial digoxin kit assay methodsR G Morris, D B Frewin, N C Saccoia, et al.
Therapeutic Drug Monitoring|January 1, 1989
Alteration in doxorubicin and doxorubicinol plasma concentrations with repeated courses to patientsR G Morris, P A Reece, B M Dale, et al.
Pageof 1